Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Healthcare logistics: Walden Group starts new nationwide GDP transport network in Germany

This image opens in the lightbox

News provided by

Walden Group

11 Sep, 2023, 10:33 GMT

Share this article

Share toX

Share this article

Share toX

  • Walden subsidiary Eurotranspharma Europe joins forces with four German healthcare carriers to establish Eurotranspharma Deutschland
  • Unique selling proposition: the only carrier fully dedicated to pharma and healthcare goods in a network with full active temperature control in both pharma ranges (2°C/8°C as well as 15°C/25°C) for both parcels and pallets
  • Starting in Q1 2024: hub and spokes structure secures nationwide service right from the beginning

PARIS, Sept. 11, 2023 /PRNewswire/ -- Hilden - The German market gets a new player for the delivery of temperature-controlled pharma and healthcare products in compliance with European GDP standards. "Eurotranspharma Deutschland GmbH will be the sole provider transporting only pharma and healthcare products in the temperature range of 2°C to 8°C as well as 15°C to 25°C in one network," says Steffen Segelke, Managing Director of the new company.  "We will provide next day delivery to Germany's 18,000 pharmacies, to hospitals, doctors, and wholesalers with all medical and pharmaceutical goods they order."

To realise these plans, Eurotranspharma, the European last mile healthcare expert of the Walden Group, has joined forces with four German healthcare distribution carriers to create Eurotranspharma Deutschland GmbH. Eurotranspharma will hold the majority share of the new company. Eurotranspharma Deutschland will work with a hub and spokes structure to cover the entire country right from the start: one central hub in the Kassel area connects regional depots across Germany. The Managing Director Steffen Segelke has more than 20 years of experience in transport and logistics in Germany and nearly 15 years specifically in the healthcare sector.

"Eurotranspharma Deutschland will benefit from both Walden Group expertise as the leading player for example in the English, French, Belgian and Dutch markets, and from local expertise thanks to our four German shareholders and Mr. Segelke," declares Stéphane Baudry, Chairman of the Walden Group. He expects the network to start in early Q1 2024. "The fleet will consist of dual-temperature vans & trucks able to transport goods in both temperature ranges needed by the clients." A major investment has also been made in the deployment of Eurotranspharma's Transport Management System and tracking solutions, developed for the specific needs of dual temperature healthcare transport activity.

Asked for the reasons why Walden is creating this new network, Baudry explains: "This project stems from our clients in the pharma and healthcare industry, asking us to provide them with integrated transport solutions in Germany fully dedicated to pharma and healthcare products. The country is a strategic market but currently has too few transport options, which has led to an increased risk for our customers and, more generally, to the healthcare supply chain for the patient."

Benoit Latteur, Eurotranspharma Europe CEO, sees three main strengths of Eurotranspharma Deutschland GmbH. "At first, there is the ability to deliver both 2°C/8°C and 15°C/25°C at the same time, thanks to a fleet of dual-temperature vehicles. This enables us to consolidate volumes, improve control of overflows and lead times, and provide a more sustainable service with fewer vehicles on the road." The second advantage he sees is that "Eurotranspharma has introduced proven processes and tools to enable real-time tracking of its fleet's location and temperature monitoring of goods." Finally, according to Latteur, "The creation of Eurotranspharma Deutschland GmbH will provide the German market with a connection to a fully integrated last mile distribution network spanning 9 countries with a pan-European approach and service level agreements." In addition, Eurotranspharma benefits from its membership within Skandi Network (www.skandi-network.com), the first collaborative European GDP transport network connecting 26 European countries on a daily basis. 

"I'm convinced that Eurotranspharma Deutschland will improve the quality of logistics service for the healthcare and pharmaceutical industries in Germany and, moreover, improve connections between Germany and the rest of Europe, both for centralised distribution matters and for import and export," concludes Steffen Segelke.

About Walden

Founded in 1951, the Walden Group is a family-owned company whose ambition is to become a global player in supply chain and logistics. Its activities are grouped around two poles of expertise: in logistics and transport of health products (with Movianto for logistics, Eurotranspharma for temperature-controlled last mile transport and Transpharma International for first mile transport) and in express transport (with Ciblex and Relais Colis). To support these activities, the subsidiary Pharma Pilot develops IT and digital solutions tailored to the specific needs of the group's customers. The Walden Group is present in 15 countries (Germany, Czech Republic, Denmark, France, Belgium, India, Ireland, Morocco, Netherlands, Poland, Romania, Slovakia, Spain, Switzerland, UK), employs more than 6,000 people on 180 sites and nearly 800,000 m² of warehouses. In 2022 the group had a turnover of €2.3 billion.
www.walden-group.com

About Eurotranspharma

Eurotranspharma is the leading European transport company 100% dedicated to healthcare products. In strict compliance with EU's Good Distribution Practices (GDP), Eurotranspharma distributes health products at controlled temperatures (2°C/8°C and 15°C/25°C). Thanks to its connected IT tools, Eurotranspharma ensures the distribution of the last mile via a unique network in Europe and a control tower allowing complete traceability from end to end. The company operates on the European market in 9 countries. Beyond its internal network, Eurotranspharma is a founding member of Skandi Network, the first collaborative network dedicated to the transport of health products. It connects 26 European countries on a daily basis.
www.eurotranspharma.com 

Contacts for press enquiries:
Laure Murat                                                               
Marketing and Communication Manager Walden Group
laure.murat@walden-group.com           

Logo - https://mma.prnewswire.com/media/2206749/Walden_Group_Logo.jpg

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.